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A 34-year-old married woman complaining of macrohematuria was admitted to our institute. 
Cystoscopy revealed a broad-stalk， nonpapillarγtumor at the urinary bladder dome， and cold欄punch
biopsy proved it to be a mucus-producing adenocarcinoma. Abdominal managnetic resonance 
imaging demonstrated a tumor extending from the umbilicus to the bladder dome， and chest computed 
tomography (CT) demonstrated a small lung tumor with calcification. Examination of the upper 
gostroinstestinal tract， barium enema， and colon fiberscopy did not reveal abnormalities. We 
therefore diagnosed an urachal carcinoma with lung metastases. Total cystectomy， umbilical-urachal 
resection， hysterectomy， ileal neobladder， and partial resection of lung were performed， followed by 
partial resection of the left lung using thoracoscopy. About 6 months later， chest CT demonstrated 
multiple metastases in the right lung. After treatment with three courses of chemotherapy (paclitaxel 
and carboplatin)， the right lung was partially resected. 
Serum CEA and CA19-91evels were used to follow her disease， since both were elevated before the 
surgery and at the recurrence. Both indicators returned to their normal ranges after treatment. Such 
cases require careful observation using imaging modalities and tumor markers. 
(Hinyokika Kiyo 51: 191-194， 2005) 




















腫蕩マーカーは CA19-969.0 U/ml (37 U/ml 以下)， 
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Fig. 1. MRI (T2-weighted image) demons-
trated a tumor extending from umbili-
cus to the bladder dome 
Fig. 2. Microscopic histopathological appear-
















癌の肺再発と考え， 2003年 l月8日から 3月27日まで
PaclitaxeIと Carboplatinを用いた全身化学療法を 3
コース施行した. Paclitaxelは 175mg/m2， Carbo-
platinは TargetAUCX (GFR+25) mgを day1に
投与し， 3週間を lサイクルとした (TargetAUC : 5 
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